ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Artificial intelligence (AI)
  • Brain cancer
  • Breast cancer
  • ComboMATCH
  • COVID-19
  • Gastrointestinal (GI) cancer
  • Genitourinary (GU) cancer
  • Head and neck cancer
  • Health equity
  • Imaging
  • Immunotherapy
  • In memory
  • Leukemia
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Personalized treatment
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data
  • Real-world evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Young adults
June 6, 2020
June 6, 2020
Categories
  • Ongoing Trials

Ongoing Trial: EA3161 is testing maintenance immunotherapy versus observation in patients with HPV-related throat cancer

This trial is comparing chemotherapy and radiation to chemotherapy and radiation plus an immunotherapy drug.
Do you like it?
0 Read more
February 10, 2020
man with kidney pain
February 10, 2020
Categories
  • Ongoing Trials

Ongoing Trial: The PROSPER RCC kidney cancer trial seeks to transform treatment for patients with renal cell carcinoma

This trial is comparing immune system therapy before and after surgery to surgery alone.
Do you like it?
0 Read more
February 9, 2020
green awareness ribbon hope
February 9, 2020
Categories
  • New Trials

Now Enrolling: Trial EA4181 is comparing three different chemotherapy treatments for newly diagnosed mantle cell lymphoma

Right now, researchers do not know the ideal treatment for people with newly diagnosed mantle cell lymphoma.
Do you like it?
0 Read more
February 4, 2020
Gerald Green headshot
February 4, 2020
Categories
  • Editorials

Planning early for late effects

Advocate Gerald Green shares his perspective on how to anticipate the late effects of cancer—and its treatment. Late effects can appear months or even years after patients finished therapy.
Do you like it?
Read more
Prev page
1234567
Next page

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc